Literature DB >> 8597878

Flush induced by fluoroquinolones in canine skin.

M Kurata1, Y Kasuga, E Nanba, H Nakamura, T Asano, K Haruta.   

Abstract

The flush induced by two fluoroquinolone antibacterial agents, balofloxacin and ofloxacin, was studied in beagle dogs. Intradermal injection of the fluoroquinolones at concentrations above 10(-5) M produced a localized flushed area. The flush responses to fluoroquinolones were inhibited by co-administration with H2-antagonist(s) (ranitidine or cimetidine), but not with H1-antagonist(s) (mepyramine or chlorpheniramine). Similar inhibitory effects of these H2-antagonists were observed for the response to histamine. The flush responses to fluoroquinolones were inhibited by a local pretreatment with compound 48/80 administered to deplete the local stores of mast cell-bound histamine. When the fluoroquinolones were orally administered at a dose of 400 mg/kg, the concentration of histamine in plasma was increased, being accompanied by systemic erythema. These results indicate that the flush induced by fluoroquinolones is mediated by histamine release from canine cutaneous mast cells and H2-receptor stimulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8597878     DOI: 10.1007/bf01837910

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  18 in total

1.  Phototoxic potential of quinolone antibacterial agents in Balb/c mice.

Authors:  N Wagai; F Yamaguchi; M Sekiguchi; K Tawara
Journal:  Toxicol Lett       Date:  1990-12       Impact factor: 4.372

2.  Blockade of histamine-mediated increases in microvascular permeability by H1- and H2-receptor antagonists.

Authors:  D E Dobbins; B T Swindall; F J Haddy; J M Dabney
Journal:  Microvasc Res       Date:  1981-05       Impact factor: 3.514

Review 3.  Fluoroquinolones. Adverse reactions during clinical trials and postmarketing surveillance.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1989-08-25

4.  General pharmacology of the new quinolone antibacterial agent levofloxacin.

Authors:  K Takasuna; Y Kasai; C Usui; M Takahashi; M Hirohashi; K Tamura; S Takayama
Journal:  Arzneimittelforschung       Date:  1992-03

5.  Identification and specific blockade of two receptors for histamine in the cardiovascular system.

Authors:  J R Powell; M J Brody
Journal:  J Pharmacol Exp Ther       Date:  1976-01       Impact factor: 4.030

6.  Canine cutaneous mast cells dispersion and histamine secretory characterization.

Authors:  F de Mora; G García; L Ferrer; M Arboix
Journal:  Vet Immunol Immunopathol       Date:  1993-12       Impact factor: 2.046

7.  Sequential therapy with i.v. and oral ofloxacin in lower respiratory tract infections: a comparative study.

Authors:  H Feist
Journal:  Infection       Date:  1991       Impact factor: 3.553

8.  Photostability and biological activity of fluoroquinolones substituted at the 8 position after UV irradiation.

Authors:  M Matsumoto; K Kojima; H Nagano; S Matsubara; T Yokota
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

9.  Reduced phototoxicity of a fluoroquinolone antibacterial agent with a methoxy group at the 8 position in mice irradiated with long-wavelength UV light.

Authors:  K Marutani; M Matsumoto; Y Otabe; M Nagamuta; K Tanaka; A Miyoshi; T Hasegawa; H Nagano; S Matsubara; R Kamide
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

10.  Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin.

Authors:  J C Foreman; C C Jordan; P Oehme; H Renner
Journal:  J Physiol       Date:  1983-02       Impact factor: 5.182

View more
  5 in total

1.  Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use.

Authors:  Bernhardt Sachs; Stefan Riegel; Jörg Seebeck; Rainer Beier; Dagmar Schichler; Antina Barger; Hans F Merk; Stephan Erdmann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 2.  Hypersensitivity reactions to fluoroquinolones.

Authors:  Kathrin Scherer; Andreas J Bircher
Journal:  Curr Allergy Asthma Rep       Date:  2005-01       Impact factor: 4.919

3.  Novel phenotype in beagle dogs characterized by skin response to compound 48/80 focusing on skin mast cell degranulation.

Authors:  Mitsuhiro Uchida; Fumi Ito; Toshiyuki Tsuchiya; Yoko Shoji; Toru Kurosawa
Journal:  Exp Anim       Date:  2015-06-09

4.  Adverse drug reaction monitoring during antimicrobial therapy for septicemia patients at a university hospital in New Delhi.

Authors:  Muhammad Shamshir Alam; Krishna Kolappa Pillai; Syed Aliul Hasan Abdi; Prem Kapur; Paru Kutty Pillai; Kandasamy Nagarajan
Journal:  Korean J Intern Med       Date:  2017-09-06       Impact factor: 2.884

5.  Female Asthmatic Patients Have Higher Risk to Develop Gemifloxacin-Associated Skin Rash, Highlighting Unique Delayed Onset Characteristics.

Authors:  Chiou-Mei Wu; Po-Ju Wei; Yu-Ting Shen; Hsu-Liang Chang; Ying-Ming Tsai; Hung-Fang Pan; Yong-Chieh Chang; Yu-Ching Wei; Chih-Jen Yang
Journal:  Antibiotics (Basel)       Date:  2019-08-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.